PANACEABIO.BOPANACEABIO.BOBSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank85
3Y CAGR-32.0%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-32.0%/yr
Quarterly compound
Percentile
P85
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 112.59% |
| Q3 2025 | -173.04% |
| Q2 2025 | 72.89% |
| Q1 2025 | -3360.78% |
| Q4 2024 | 39.29% |
| Q3 2024 | 92.61% |
| Q2 2024 | -53.00% |
| Q1 2024 | -60.37% |
| Q4 2023 | 28.05% |
| Q3 2023 | -133.55% |
| Q2 2023 | 484.60% |
| Q1 2023 | -128.18% |
| Q4 2022 | 357.83% |
| Q3 2022 | 57.53% |
| Q2 2022 | 12.53% |
| Q1 2022 | -2921.60% |
| Q4 2021 | 126.84% |
| Q3 2021 | 61.30% |
| Q2 2021 | -154.23% |
| Q1 2021 | -229.17% |
| Q4 2020 | -85.58% |
| Q3 2020 | 137.56% |
| Q2 2020 | -46.62% |
| Q1 2020 | -19.57% |
| Q4 2019 | 252.96% |
| Q3 2019 | -242.01% |
| Q2 2019 | 146.99% |
| Q1 2019 | 3.07% |
| Q4 2018 | -12.78% |
| Q3 2018 | -166.44% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q3 2015 | 0.00% |